Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study

To evaluate the safety and exploratory efficacy of intratympanic administration of OTO-313 in patients with tinnitus. STUDY DESIGN: Single intratympanic injection of OTO-313 evaluated in a randomized, double-blind, placebo-controlled Phase 1/2 clinical study. SETTING: Tertiary referral centers. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Maxwell, Kenneth S., Robinson, James M., Hoffmann, Ines, Hou, Huiying J., Searchfield, Grant, Baguley, David M., McMurry, Gordon, Piu, Fabrice, Anderson, Jeffery J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Medical Neurotology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584222/
https://www.ncbi.nlm.nih.gov/pubmed/34629442
http://dx.doi.org/10.1097/MAO.0000000000003369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584222/
https://www.ncbi.nlm.nih.gov/pubmed/34629442
http://dx.doi.org/10.1097/MAO.0000000000003369

Ejemplares similares